Drug Discovery

Millennium gains immediate license to one antigen and has option rights to two more. Millennium: The Takeda Oncology Company is paying Seattle Genetics $4 million...

Comprehensive genome sequencing is now fast enough and informative enough to help treat pediatric cancer patients in real time, according to a clinical study...

On the basis of the complementarity-determining region (CDR) in cow antibodies, scientists have developed CDR human antibody-hormone fusions with long-lasting functionality.

Ministry of Health and Welfare cleares oral drug for preventing VTE after major orthopaedic surgery.

Deal aimed at strengthening buyer's capabilities in large molecule bioanalysis and expanding its global presence

Higher exposure to commonly used oral antibiotics is linked to an increased risk of Parkinson's disease according to a recently published study by researchers from the Helsinki University Hospital, Finland. The study suggests that excessive use of certain antibiotics can predispose to Parkinson's disease with a delay of up to 10 to 15 years. This connection may be explained by their disruptive effects on the gut microbial ecosystem.

The Cancer Genome Atlas Research Network hope findings will help to improve treatment decision making, monitor patients after therapy, and identify new therapeutic targets

Vaccine is reportedly the first in which gene customization has been used successfully to control virulence in bacteria.

Variance in gut microbiome composition has been correlated with fibromyalgia, a hard-to-diagnose syndrome characterized by fatigue, impaired sleep, cognitive difficulties, and (most of all) widespread chronic pain

StressMarq Biosciences negotiated a nonexclusive commercial license to use U.K. firm Innova Biosciences’ Lightning-Link® technology for the development of antibody conjugate research tools.